| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$4,615,667 ) (Continued on the next page) |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 001 | 2 | NIH | 12/5/2024 | $334,821 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 000 | 9 | NIH | 3/28/2025 | $432,620 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 007 | 6 | NIH | 2/12/2025 | $564,238 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 007 | 6 | NIH | 2/12/2025 | $2,228,484 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG089917 | Cathepsin-L mediated remodeling of the nuclear proteome | 000 | 1 | NIH | 11/13/2024 | $227,250 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 000 | 3 | NIH | 12/6/2024 | $53,974 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DC019566 | Pharmacological Approaches for Transepithelial Delivery of Therapeutics to the Vocal Folds | 000 | 4 | NIH | 3/27/2025 | $464,064 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 000 | 3 | NIH | 12/17/2024 | $462,823 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI150610 | Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | 000 | 5 | NIH | 2/13/2025 | $661,369 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K22CA279495 | Elucidating Mechanisms of CAR ML NK cell biology to treat cancer and infection | 000 | 2 | NIH | 12/18/2024 | $186,030 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 000 | 3 | NIH | 12/12/2024 | $484,531 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21NS137054 | Unraveling how neuropathic pain synaptic transcriptome is signaled by G-quadruplex folds | 000 | 2 | NIH | 2/14/2025 | $227,250 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23DA053433 | A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women | 000 | 4 | NIH | 3/21/2025 | $177,884 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL049413 | Structural basis of prothrombin activation | 000 | 28 | NIH | 3/26/2025 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL049413 | Structural basis of prothrombin activation | 002 | 28 | NIH | 3/28/2025 | $93,194 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI142672 | Innate immune response of LTBI+HIV+ children | 002 | 5 | NIH | 2/12/2025 | $305,214 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 001 | 1 | NIH | 11/27/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 001 | 1 | NIH | 11/27/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 03 | 1 | HRSA | 1/22/2025 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 000 | 1 | NIH | 11/19/2024 | -$146,530 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM149320 | Coordination of DNA Metabolism by Replication Protein A | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U01DK061718 | The Saint Louis University Component of the NASH Clinical Research Network | 001 | 23 | NIH | 3/5/2025 | $120,945 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U01DK061718 | The Saint Louis University Component of the NASH Clinical Research Network | 000 | 22 | NIH | 3/5/2025 | -$120,945 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 001 | 5 | NIH | 2/18/2025 | $2,581 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA271033 | Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV) | 001 | 2 | NIH | 2/19/2025 | -$1 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL049413 | Structural basis of prothrombin activation | 001 | 27 | NIH | 3/28/2025 | -$93,194 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM141652 | Function and Regulation of a Novel Membrane-Associated Deubiquitinating Enzyme | 000 | 1 | NIH | 1/29/2025 | -$614 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA263428 | Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer | 001 | 2 | NIH | 2/12/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG076812 | Providers and Older Pain Patients with Prescription Opioid Dependence: A Qualitative Study to Understand Barriers to Opioid Taper, Cessation, and Transition to Buprenorphine. | 000 | 1 | NIH | 1/16/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R25AI170379 | NIAID STAR: Stimulating Training and Access to Research Experiences for Minority and Underrepresented Populations | 001 | 2 | NIH | 1/21/2025 | -$8,078 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA238705 | Defining how obesity shapes immunity and the success of cancer immunotherapy | 000 | 5 | NIH | 12/4/2024 | -$5,560 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA263428 | Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer | 000 | 2 | NIH | 1/3/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30HL151136 | Mechanistic investigations of Granzyme A-mediated γ9δ2 T cell TB protective effects | 000 | 4 | NIH | 3/25/2025 | -$2,603 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | MC142100 | Behavioral Health Workforce Education and Training Program- American Rescue Plan | 03 | 3 | HRSA | 3/5/2025 | $0 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56AG076145 | Role of self-DNA and sterile inflammation driving age/progeria-related metabolic defects | 000 | 1 | NIH | 3/26/2025 | -$280 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA271033 | Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV) | 000 | 1 | NIH | 2/19/2025 | -$97,804 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AI165081 | Mechanisms of retroviral integrase-DNA complexes assembly | 000 | 2 | NIH | 2/13/2025 | -$9,727 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56HL165199 | Insulin regulation of lymphatic vessel integrity | 000 | 1 | NIH | 3/18/2025 | -$1,654 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 006 | 3 | NIH | 1/27/2025 | -$990,117 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 004 | 3 | NIH | 1/27/2025 | -$151,855 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R25AI170379 | NIAID STAR: Stimulating Training and Access to Research Experiences for Minority and Underrepresented Populations | 000 | 1 | NIH | 1/21/2025 | -$58,993 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK118340 | Integrative Physiology of Obesity: Role of GPR160 | 000 | 5 | NIH | 12/4/2024 | $0 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 005 | 3 | NIH | 1/27/2025 | -$123,097 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UH3HD096929 | Innovative Tools to Expand Youth-Friendly HIV Self-Testing (I-TEST) | 001 | 4 | NIH | 12/3/2024 | -$134,672 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UH3HD096929 | Innovative Tools to Expand Youth-Friendly HIV Self-Testing (I-TEST) | 000 | 5 | NIH | 12/3/2024 | -$729,628 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 000 | 4 | NIH | 2/18/2025 | -$2,581 |
| | 2025 | 2021 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AI151936 | A new target for host-directed therapy against TB infection | 000 | 2 | NIH | 2/19/2025 | -$14 |
| | 2025 | 2021 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21NR017978 | The Social Context of Live Discharge from Hospice for Family Caregivers of Patients with Alzheimer's Disease and Related Dementias | 001 | 1 | NIH | 11/26/2024 | -$2,202 |
|
